Johnathan Cohen., Founder, and Chief Executive Officer, 20/20 GeneSystems Inc. joins Rich Bendis to discuss cancer diagnostics, crowdfunding, and where his company is headed. Under Mr. Cohen’s leadership, 20/20 GeneSystems has brought in approximately $7.5 million in grant funding and launched two successful products, a kit for suspicious powders used by hundreds of emergency responder organizations worldwide and a blood test for the early detection of lung cancer.
Listen now on
,
, and
.
